iShares Biotechnology ETF (NASDAQ:IBB) Shares Acquired by Bigelow Investment Advisors LLC

Bigelow Investment Advisors LLC grew its position in iShares Biotechnology ETF (NASDAQ:IBB) by 13.4% in the 4th quarter, Holdings Channel.com reports. The fund owned 8,347 shares of the financial services provider’s stock after acquiring an additional 987 shares during the quarter. Bigelow Investment Advisors LLC’s holdings in iShares Biotechnology ETF were worth $1,104,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also modified their holdings of the company. Darwin Wealth Management LLC acquired a new stake in shares of iShares Biotechnology ETF in the third quarter valued at approximately $29,000. Highline Wealth Partners LLC acquired a new stake in shares of iShares Biotechnology ETF during the third quarter worth $30,000. HHM Wealth Advisors LLC lifted its holdings in shares of iShares Biotechnology ETF by 200.0% during the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 150 shares during the period. Ashton Thomas Securities LLC acquired a new stake in shares of iShares Biotechnology ETF during the third quarter worth $36,000. Finally, Newbridge Financial Services Group Inc. acquired a new stake in shares of iShares Biotechnology ETF during the fourth quarter worth $33,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Up 0.4 %

Shares of NASDAQ IBB opened at $137.11 on Wednesday. The stock has a fifty day moving average price of $135.55 and a 200 day moving average price of $140.81. iShares Biotechnology ETF has a 1-year low of $123.60 and a 1-year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.